Skip to main content
. Author manuscript; available in PMC: 2020 Nov 23.
Published in final edited form as: J Cardiopulm Rehabil Prev. 2020 May;40(3):174–177. doi: 10.1097/HCR.0000000000000459

Table 2.

Exercise Testing Values of the Study Populationa

Variable BB
n = 59
NBB
n = 115)
P Value
BB Versus
NBB
HRrest, bpm 66 ± 12.2 70 ± 10.6 .038b
HRsubmax, bpm 92 ± 16.2 99 ± 15.2 .007b
HRpeak, bpm 123 ± 19.8 129 ± 20.1 .073
HRreserv, bpm 57 ± 17.1 59 ± 17.4 .464
HRrec1, bpm 103 ± 18.9 109 ± 16.9 .023b
HRrecov, bpm 20 ± 12.3 20 ± 11.0 .699
Peak blood pressure, mm Hg
 Systolic 190 ± 26.2 183 ± 24.2 .093
 Diastolic 86 ± 11.4 86 ± 11.3 .962
V˙o2rest, mL·kg−1·min−1 3.4 ± 0.6 3.4 ± 0.5 .711
V˙o2submax, mL·kg−1·min−1 8.6 ± 1.4 8.5 ± 1.5 .586
V˙o2peak, mL·kg−1 ·min−1 14.1 ± 3 13.8 ± 2.9 .479
RERpeak 1.1 ± 0.1 1.1 ± 0.1 .863

Abbreviations: BB, participants with β-blocker therapy; HRpeak, peak HR; HRrec1, heart rate at 1-min recovery; HRrecov, heart rate recovery = (HRpeak− HRrec1); HRreserv, heart rate Reserve = (HRpeak− HRrest); HRrest, resting HR; HRsubmax, HR at submaximal load; NBB, participants with no β-blocker therapy; RERpeak, peak respiratory exchange ratio; V˙o2peak, peak oxygen uptake; V˙o2rest, resting oxygen uptake; V˙o2submax, submaximal oxygen uptake.

a

Values are means ± SD.

b

Significantly different from BB (P < .05).